Gateway to Biotech: Top researchers met industry experts in the Faculty Club at IZB

May 16, 2019

Michael Almstetter, CEO Origenis GmbH, explained what can be learned from progress in oncology in order to develop new treatments for Alzheimer’s and Parkinson’s disease.